These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6260340)

  • 1. Pharmacokinetics of vincristine in the cerebrospinal fluid of humans.
    Jackson DV; Sethi VS; Spurr CL; McWhorter JM
    Cancer Res; 1981 Apr; 41(4):1466-8. PubMed ID: 6260340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of vincristine in the cerebrospinal fluid of subhuman primates.
    Jackson DV; Castle MC; Poplack DG; Bender RA
    Cancer Res; 1980 Mar; 40(3):722-4. PubMed ID: 7471091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of vincristine infusion.
    Jackson DV; Sethi VS; Spurr CL; White DR; Richards F; Stuart JJ; Muss HB; Cooper MR; Castle MC
    Cancer Treat Rep; 1981; 65(11-12):1043-8. PubMed ID: 7296550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of vincristine sulfate in adult cancer patients.
    Sethi VS; Jackson DV; White DR; Richards F; Stuart JJ; Muss HB; Cooper MR; Spurr CL
    Cancer Res; 1981 Sep; 41(9 Pt 1):3551-5. PubMed ID: 7260915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot study of high-dose 1-beta-D-arabinofuranosylcytosine for acute leukemia and refractory lymphoma: clinical response and pharmacology.
    Early AP; Preisler HD; Slocum H; Rustum YM
    Cancer Res; 1982 Apr; 42(4):1587-94. PubMed ID: 6949642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid pharmacokinetics of intraventricular and intravenous aziridinylbenzoquinone.
    Zimm S; Collins JM; Curt GA; O'Neill D; Poplack DG
    Cancer Res; 1984 Apr; 44(4):1698-701. PubMed ID: 6704975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid concentrations of vincristine after bolus intravenous dosing: a surrogate marker of brain penetration.
    Kellie SJ; Barbaric D; Koopmans P; Earl J; Carr DJ; de Graaf SS
    Cancer; 2002 Mar; 94(6):1815-20. PubMed ID: 11920545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose idarubicin in combination with Ara-C in patients with relapsed or refractory acute lymphoblastic leukemia: a pharmacokinetic and clinical study.
    Tedeschi A; Montillo M; Strocchi E; Cafro AM; Tresoldi E; Intropido L; Nichelatti M; Marbello L; Baratè C; Camaggi CM; Morra E
    Cancer Chemother Pharmacol; 2007 May; 59(6):771-9. PubMed ID: 17256136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-asparaginase pharmacokinetics and asparagine levels in cerebrospinal fluid of rhesus monkeys and humans.
    Riccardi R; Holcenberg JS; Glaubiger DL; Wood JH; Poplack DG
    Cancer Res; 1981 Nov; 41(11 Pt 1):4554-8. PubMed ID: 6895481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid levels of 2'-deoxycoformycin after systemic administration in monkeys.
    Blatt J; Venner PM; Riccardi R; Cohen LF; Gangji D; Glazer RI; Poplack DG
    J Natl Cancer Inst; 1982 Mar; 68(3):391-3. PubMed ID: 6977672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-2 and blood brain barrier in cats: pharmacokinetics and tolerance following intrathecal and intravenous administration.
    Martin R; Schwuléra U; Menke G; Rudolph W; Buch K; Fasold H; Lissner R; Thrun A; Krauseneck P; Bogdahn U
    Eur Cytokine Netw; 1992; 3(4):399-406. PubMed ID: 1421012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of methotrexate in cerebrospinal fluid and serum after osmotic blood-brain barrier disruption in patients with brain lymphoma.
    Zylber-Katz E; Gomori JM; Schwartz A; Lossos A; Bokstein F; Siegal T
    Clin Pharmacol Ther; 2000 Jun; 67(6):631-41. PubMed ID: 10872645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCL13 and CXCL12 in central nervous system lymphoma patients.
    Fischer L; Korfel A; Pfeiffer S; Kiewe P; Volk HD; Cakiroglu H; Widmann T; Thiel E
    Clin Cancer Res; 2009 Oct; 15(19):5968-73. PubMed ID: 19773382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacokinetics of intrathecal chemotherapy and clinical problems].
    Fujimoto T
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1536-42. PubMed ID: 6433796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of cladribine (2-chlorodeoxyadenosine) in children with acute leukemia.
    Kearns CM; Blakley RL; Santana VM; Crom WR
    Cancer Res; 1994 Mar; 54(5):1235-9. PubMed ID: 7906999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrathecal chemotherapy for patients with meningeal carcinomatosis.
    Yoshida S; Morii K
    Surg Neurol; 2005 Jan; 63(1):52-5; discussion 55. PubMed ID: 15639526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid polyamines in childhood leukemia.
    Smith BJ; Lee S; Sabio H; Wills MR; Savory J
    Ann Clin Lab Sci; 1984; 14(3):225-31. PubMed ID: 6587824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum and cerebrospinal fluid distribution of 5-methyltetrahydrofolate after intravenous calcium leucovorin and intra-Ommaya methotrexate administration in patients with meningeal carcinomatosis.
    Mehta BM; Glass JP; Shapiro WR
    Cancer Res; 1983 Jan; 43(1):435-8. PubMed ID: 6600162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contamination of cerebrospinal fluid specimens with hematogenous blasts in patients with leukemia.
    Rohlfing MB; Barton TK; Bigner SH; Johnston WW
    Acta Cytol; 1981; 25(6):611-5. PubMed ID: 6947666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma and cerebrospinal fluid pharmacokinetics of acivicin in Ommaya reservoir-bearing rhesus monkeys.
    McGovren JP; Stewart JC; Elfring GL; Smith RB; Soares N; Wood JH; Poplack DG; Von Hoff DD
    Cancer Treat Rep; 1982 Jun; 66(6):1333-41. PubMed ID: 7083237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.